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Human Biomonitoring (HBM) and surveys with a health 
examination component are very similar regarding infrastructure 
and procedures necessary for their implementation. Both rely on 
planned fieldwork for collection of data and biological materials, 
which usually needs considerable financing. Thus, combined 
planning and fieldwork could result in more cost-effective ways 
to conduct health and environmental monitoring. As such, within 
the HBM4EU project an inventory of the health studies available 
which could include an HBM module was performed. 
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BACKGROUND 
An online questionnaire was developed to collect information on 
recently conducted, ongoing or planned health studies in the EU 
and EEA countries, in which an HBM module could be included. 
The link to the questionnaire was distributed with the help of the 
National Hub Contact Points of the HBM4EU project. 
METHODS 
HBM4EU has received funding from the European Union’s Horizon 2020 
research and innovation programme (grant agreement 733032). 
FUNDING 
In vast majority of the studies included in the inventory, 
biological samples were collected and stored, raising question of 
its use in HBM studies for the analyses of chemicals of interest. 
About 50% of these studies already had ethical approval to 
measure chemicals from collected samples. 
CONCLUSIONS 
Half of the studies were longitudinal and presented the 
possibility of introducing an HBM component in the future 
(Figure 2). 
RESULTS 
The vast majority of the studies which did not have an HBM 
component, included the collection and storage of biological 
samples, frequently blood, plasma, serum or DNA (Figures 4 
and 5). 
Most studies for which data was reported had public funding 
either from governments or from other public grants (national or 
European) (Figure 3). 
More than 50%  of the studies reported that measurement of 
chemicals had already performed or was planned to be 
performed. The most frequently measured chemicals were 
phthalates, bisphenols and cadmium. 
From the 58 different studies included in this inventory, one 
quarter were health examination surveys (HES), one quarter 
were targeted health studies and another quarter were 
combined HES and HBM surveys (Figure 1). 
Figure 1 – Survey type in EU and EEA countries (1999 to 2019) 
Figure 2 – Type of study in EU and EEA countries (1999 to 2019) 
Figure 3 – Funding source per type of study in EU and EEA countries (1999 to 2019) 
Figure 4 – Collection of biological samples in EU health studies (1999 to 2019) 
Figure 5 – Biological samples collected per survey type in EU and EEA countries (1999 to 2019) 
Figure 7 – Chemicals measured per survey type in EU and EEA countries (1999 to 2019) 
Figure 6 – Measurement of chemicals (performed or planned) 
